×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GANX – gain therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GANX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/19
03:03 pm
ganx
Gain Therapeutics (NASDAQ:GANX) had its "buy" rating reaffirmed by analysts at Roth Capital.
Medium
Report
Gain Therapeutics (NASDAQ:GANX) had its "buy" rating reaffirmed by analysts at Roth Capital.
12/19
08:04 am
ganx
Gain Therapeutics (NASDAQ:GANX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
High
Report
Gain Therapeutics (NASDAQ:GANX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
12/18
04:05 pm
ganx
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
High
Report
Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease
12/18
07:32 am
ganx
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson's Disease [Yahoo! Finance]
High
Report
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson's Disease [Yahoo! Finance]
12/18
07:00 am
ganx
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
High
Report
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
12/11
04:18 pm
ganx
Gain Therapeutics (NASDAQ:GANX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Gain Therapeutics (NASDAQ:GANX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/5
04:20 pm
ganx
Gain Therapeutics (NASDAQ:GANX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Gain Therapeutics (NASDAQ:GANX) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/1
07:20 am
ganx
Gain Therapeutics (NASDAQ:GANX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Gain Therapeutics (NASDAQ:GANX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/18
09:01 am
ganx
Form 8-K Gain Therapeutics, Inc. For: Dec 18
High
Report
Form 8-K Gain Therapeutics, Inc. For: Dec 18
12/3
04:02 pm
ganx
Form S-8 Gain Therapeutics, Inc.
Medium
Report
Form S-8 Gain Therapeutics, Inc.
11/28
04:03 pm
ganx
Form 8-K Gain Therapeutics, Inc. For: Nov 28
Medium
Report
Form 8-K Gain Therapeutics, Inc. For: Nov 28
11/28
04:02 pm
ganx
Form 424B5 Gain Therapeutics, Inc.
Medium
Report
Form 424B5 Gain Therapeutics, Inc.
11/12
04:10 pm
ganx
Form 10-Q Gain Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q Gain Therapeutics, Inc. For: Sep 30
11/12
04:08 pm
ganx
Form 8-K Gain Therapeutics, Inc. For: Nov 12
Medium
Report
Form 8-K Gain Therapeutics, Inc. For: Nov 12
11/7
04:06 pm
ganx
Form S-3/A Gain Therapeutics, Inc.
High
Report
Form S-3/A Gain Therapeutics, Inc.
10/14
04:57 pm
ganx
Form 8-K Gain Therapeutics, Inc. For: Oct 14
Medium
Report
Form 8-K Gain Therapeutics, Inc. For: Oct 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: